CDKN3 and cancer: In these cancers, high expression of CDKN3 indicates poor prognosis. In our current study, Oncomine analysis showed that CDKN3 was significantly elevated in anaplastic oligoastrocytoma, leukaemia, HCC, and sarcoma.